Epidemiology and Risk Factors of Uterine Fibroids in China

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

20000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-06-19

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Uterine fibroids are the most common form of benign uterine tumors in the uterine muscle layer, which had a certain rate of malignancy, but it is rare. The prevalence of uterine fibroids estimates range from 4.5% to 68.6% depending on study population and diagnostic methodology. The prevalence of fibroids has been historically underestimated by epidemiologic studies which focused mainly on symptomatic women, leaving behind a large population of asymptomatic women and women who underreport their symptoms. What investigators don't know was which women who have fibroids will develop clinical symptoms and which women who have an operation of myomectomy will relapse. The purpose of this study is to investigate the prevalence, incidence and risk factors for the development of uterine fibroids in Chinese women.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Risk Factors and A Prediction Model of Recurrence of Uterine Fibroids

NCT06234670

Uterine Fibroid Recurrence

NOT_YET_RECRUITING

Radiomics-Based Non-Invasive MRI Differentiation of Uterine Sarcomas and Fibroids

NCT07129005

Uterine Fibroid Uterine Sarcoma Diagnose Disease +1 more

ENROLLING_BY_INVITATION

China Clinical Trial for Therapeutic MR-HIFU Ablation of Uterine Fibroids

NCT01588899

Uterine Fibroids

COMPLETED NA

Study of Volume Reduction of Uterine Fibroids After Embolization or Microwave Treatment

NCT02942537

Uterine Fibroids

UNKNOWN PHASE2/PHASE3

Establishment of a Decision Aid Tool for Asymptomatic Small Leiomyoma and Analysis of Influencing Factors for Clinical Decision-making Using HIFU

NCT05500118

Leiomyoma, Uterine High-Intensity Focused Ultrasound Ablation Patients Decision Aids

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Uterine Fibroid

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Current place of residence≥ 6 months;
* No serious mental illness or mental abnormality;
* Those who agree to participate in this survey and cooperate in completing the questionnaire.